Roman Butler Fullerton & Co’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
Roman Butler Fullerton & Co's EXEL Position: Q2 2026 in Review
Roman Butler Fullerton & Co sold out of Exelixis (EXEL) in Q2 2026, closing a stake of 15,277 shares — an estimated $675K sold.
Roman Butler Fullerton & Co first reported a position in EXEL in Q3 2025 and held it in 2 quarters. The position peaked at $675K in Q1 2026. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.
- Roman Butler Fullerton & Co reported no remaining Exelixis position as of Q2 2026 after selling out during the quarter.
- Roman Butler Fullerton & Co sold 15,277 Exelixis shares in Q2 2026, an estimated $675K.
- Roman Butler Fullerton & Co first reported a position in Exelixis in Q3 2025 and held it in 2 quarters.
- Roman Butler Fullerton & Co's Exelixis position peaked at $675K in Q1 2026.
- 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.
Based on Roman Butler Fullerton & Co's 13F filing for Q2 2026, filed 6 Aug 2026.